I'm currently conducting a meta-analysis of pharmacist-led health interventions and their effect on levels of medication adherence. One of my studies has a phased intervention design. This means that Group A of participants received the intervention first, and three months later Group B of participants received the same intervention. Both groups were measured using the same tool for medication adherence. The study presents medication adherence means for both groups, at baseline, 3 months and 6 months post-intervention.

If I want to include this study in my meta-analysis, can I just take the overall mean level of medication adherence of the two groups (A & B) for each time point?

  • $\begingroup$ This looks from your description as though it is an example of a waiting list control. Can you clarify that by editing your question? $\endgroup$ – mdewey Jun 3 '17 at 13:10

Your Answer

By clicking “Post Your Answer”, you agree to our terms of service, privacy policy and cookie policy

Browse other questions tagged or ask your own question.